These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22484859)

  • 1. Predictive markers in early research and companion diagnostic developments in oncology.
    Pickl M; Ruge E; Venturi M
    N Biotechnol; 2012 Sep; 29(6):651-5. PubMed ID: 22484859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in biomarkers for cancer diagnosis and treatment.
    Manne U; Srivastava RG; Srivastava S
    Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best practices for companion diagnostic and therapeutic development: translating between the stakeholders.
    Love D; Stratton E; Stocum M
    N Biotechnol; 2012 Sep; 29(6):689-94. PubMed ID: 22743138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biomarker is not the end.
    Nohaile M
    Drug Discov Today; 2011 Oct; 16(19-20):878-83. PubMed ID: 21888986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commercialized multigene predictors of clinical outcome for breast cancer.
    Ross JS; Hatzis C; Symmans WF; Pusztai L; Hortobágyi GN
    Oncologist; 2008 May; 13(5):477-93. PubMed ID: 18515733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular tools for companion diagnostics.
    Zieba A; Grannas K; Söderberg O; Gullberg M; Nilsson M; Landegren U
    N Biotechnol; 2012 Sep; 29(6):634-40. PubMed ID: 22634023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualification of imaging biomarkers for oncology drug development.
    Waterton JC; Pylkkanen L
    Eur J Cancer; 2012 Mar; 48(4):409-15. PubMed ID: 22226478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic biomarkers for molecular cancer therapeutics.
    Sarker D; Workman P
    Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of multiplexed assay systems for molecular diagnostics.
    Schwarz E; VanBeveren NJ; Guest PC; Izmailov R; Bahn S
    Int Rev Neurobiol; 2011; 101():259-78. PubMed ID: 22050855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular testing in oncology: problems, pitfalls and progress.
    O'Brien CP; Taylor SE; O'Leary JJ; Finn SP
    Lung Cancer; 2014 Mar; 83(3):309-15. PubMed ID: 24472389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating basic research in cancer patient care.
    Maugeri-Saccà M; De Maria R
    Ann Ist Super Sanita; 2011; 47(1):64-71. PubMed ID: 21430342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M; Torchio M; Mazzini G
    Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From research to regulated: challenges in transferring methods.
    Chowdhury F; Williams A
    Bioanalysis; 2009 May; 1(2):285-91. PubMed ID: 21083167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical perspectives of personalized healthcare in oncology.
    Hodgson DR; Wellings R; Harbron C
    N Biotechnol; 2012 Sep; 29(6):656-64. PubMed ID: 22426411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic biomarkers for patient selection and stratification: the cancer paradigm.
    Moschos SA
    Bioanalysis; 2012 Oct; 4(20):2499-511. PubMed ID: 23157358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.